Stock Market Reviews

Read and share opinions on CADL (Candel Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

Latest News

• Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London
  Nov 3, 2025
• Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board
  Oct 16, 2025
• Candel Therapeutics announces interim data from phase 1b CAN-3110 trial
  Oct 15, 2025
• Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
  Oct 14, 2025
• Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
  Oct 14, 2025
• Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
  Oct 14, 2025
• Candel Therapeutics to Present at the SITC 2025 Annual Meeting
  Oct 3, 2025
• Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
  Sep 29, 2025
• Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
  Sep 17, 2025
• Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board
  Sep 2, 2025
• Candel Therapeutics to Participate in Upcoming Investor Conferences in September
  Aug 28, 2025
• With 44% stake, Candel Therapeutics, Inc. (NASDAQ:CADL) seems to have captured institutional investors' interest
  Aug 7, 2025
• Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference
  Jul 30, 2025
• Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer
  Jul 24, 2025
• Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
  Jul 9, 2025
• One Candel Therapeutics Insider Raised Stake By 22% In Previous Year
  Jun 27, 2025